Skip to main content
SpringerLink
Log in

Radioembolization Working in Synergy with Chemotherapy in NET, but can Dosimetry Bring us Even Further?

  • Commentary
  • Commentary
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Soulen MC, Teitelbaum UR, Mick R, Eads J, Mondschein JI, Dagli M, et al. Integrated capecitabine-temozolomide with radioembolization for liver-dominant G2 NETs: long-term outcomes of a single-institution retrospective study. Cardiovasc Intervent Radiol. 2023. https://doi.org/10.1007/s00270-023-03614-8.

    Article  PubMed  Google Scholar 

  2. Reinders MTM, Mees E, Powerski MJ, Bruijnen RCG. Radioembolisation in Europe: a survey amongst CIRSE members. Cardiovasc Intervent Radiol. 2018. https://doi.org/10.1007/s00270-018-1982-4.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kim SP, Cohalan C, Kopek N, Enger SA. A guide to 90Y radioembolization and its dosimetry. Phys Medica. 2019;68:132–45. https://doi.org/10.1016/j.ejmp.2019.09.236.

    Article  Google Scholar 

  4. Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, De Baere T, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6:17–29.

    Article  PubMed  Google Scholar 

  5. Doyle PW, Workman CS, Grice JV, McGonigle TW, Huang S, Borgmann AJ, et al. Partition dosimetry and outcomes of metastatic neuroendocrine tumors after yttrium-90 resin microsphere radioembolization. J Vasc Interv Radiol. 2023. https://doi.org/10.1016/j.jvir.2023.10.015.

    Article  PubMed  Google Scholar 

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

    Maarten Smits & Arthur Braat

Authors
  1. Maarten Smits
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arthur Braat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maarten Smits.

Ethics declarations

Conflict of interest

MS is a consultant for Philips, Terumo/Quirem medical and Swedish Orphan Biovitrum. AB is consultant for Boston Scientific, GE Healthcare, Terumo/Quirem medical and receives research support from Ariceum Therapeutics. The UMC Utrecht receives royalties from Terumo / Quirem medical.

Ethical Approval

Not applicable.

Informed Consent

Not applicable.

Consent for Publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smits, M., Braat, A. Radioembolization Working in Synergy with Chemotherapy in NET, but can Dosimetry Bring us Even Further?. Cardiovasc Intervent Radiol 47, 529–530 (2024). https://doi.org/10.1007/s00270-024-03678-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-024-03678-0

Search

Navigation